Select Medical Shares Drop 14.1% on Weak Q4 Results, Creating Potential Buying Opportunity
Key Metrics Miss Estimates, Revenue and EBITDA Guidance Falls Short
Healthcare services provider Select Medical (NYSE: SEM) saw its shares plunge 14.1% in pre-market trading after reporting below-par fourth-quarter 2024 results. The company missed on key operating metrics, and its full-year revenue and EBITDA guidance came in below Wall Street expectations.
Market Reaction: Volatility and Sharp Price Decline
Select Medical's stock has historically exhibited low volatility. However, the significant price drop indicates a notable impact on the market's sentiment towards the company.
Historical Performance and Investment Value
Year-to-date, SEM has declined by 5.4%. At $17.77 per share, it currently trades 55.8% below its 52-week high of $40.20. Over the past five years, investors who invested $1,000 in SEM would now hold an investment valued at $629.92.
Potential Buying Opportunity
Stock markets often overreact to news, potentially creating opportunities to acquire high-quality stocks at discounted prices. Select Medical's disappointing results may present such an opportunity.
Further Insights and Analysis
For a comprehensive analysis of Select Medical, including expert insights and investment recommendations, access our free report here.